Generation of a Pure Culture of Neuron-like Cells with a Glutamatergic Phenotype from Mouse Astrocytes
Overview
Affiliations
Astrocyte-to-neuron reprogramming is a promising therapeutic approach for treatment of neurodegenerative diseases. The use of small molecules as an alternative to the virus-mediated ectopic expression of lineage-specific transcription factors negates the tumorigenic risk associated with viral genetic manipulation and uncontrolled differentiation of stem cells. However, because previously developed methods for small-molecule reprogramming of astrocytes to neurons are multistep, complex, and lengthy, their applications in biomedicine, including clinical treatment, are limited. Therefore, our objective in this study was to develop a novel chemical-based approach to the cellular reprogramming of astrocytes into neurons with high efficiency and low complexity. To accomplish that, we used C8-D1a, a mouse astrocyte cell line, to assess the role of small molecules in reprogramming protocols that otherwise suffer from inconsistencies caused by variations in donor of the primary cell. We developed a new protocol by which a chemical mixture formulated with Y26732, DAPT, RepSox, CHIR99021, ruxolitinib, and SAG rapidly and efficiently induced the neural reprogramming of astrocytes in four days, with a conversion efficiency of 82 ± 6%. Upon exposure to the maturation medium, those reprogrammed cells acquired a glutaminergic phenotype over the next eleven days. We also demonstrated the neuronal functionality of the induced cells by confirming KCL-induced calcium flux.
Using Small Molecules to Reprogram RPE Cells in Regenerative Medicine for Degenerative Eye Disease.
Rzhanova L, Alpeeva E, Aleksandrova M Cells. 2024; 13(23).
PMID: 39682681 PMC: 11640686. DOI: 10.3390/cells13231931.
Reprogramming stem cells in regenerative medicine.
Mao J, Saiding Q, Qian S, Liu Z, Zhao B, Zhao Q Smart Med. 2024; 1(1):e20220005.
PMID: 39188749 PMC: 11235200. DOI: 10.1002/SMMD.20220005.
A promise for neuronal repair: reprogramming astrocytes into neurons in vivo.
Huang L, Lai X, Liang X, Chen J, Yang Y, Xu W Biosci Rep. 2024; 44(1).
PMID: 38175538 PMC: 10830445. DOI: 10.1042/BSR20231717.
Chen J, Huang L, Yang Y, Xu W, Qin Q, Qin R Brain Sci. 2023; 13(3).
PMID: 36979334 PMC: 10046178. DOI: 10.3390/brainsci13030524.
Fernandes G, Singh R, De D, Kim K Int J Stem Cells. 2023; 16(2):156-167.
PMID: 36823979 PMC: 10226862. DOI: 10.15283/ijsc22183.